Itaconix plc - Private Placing

Megan Dempster - LGB - February 2023

During February, LGB investors were invited to participate in an EIS-qualifying private placing for Itaconix PLC (ITX), a New Hampshire based company listed on AIM. The company was founded in 2008 to exploit the discovery at the University of New Hampshire of a technique to polymerise the plant-based material, itaconic acid, which has been the subject of research by major chemicals companies including Rohm & Haas since the 1960s. Today it produces functional ingredients which offer higher performance and non-hydrocarbon-based alternatives to existing, often polluting, chemical materials giving major FMCG customers an opportunity to reduce their carbon footprint without compromising product performance. The company qualifies for the Green Economy Mark of the London Stock Exchange, which recognises companies that derive 50% or more of their total annual revenues from products and services that contribute to the global green economy. It is therefore an interesting proposition in the context of our theme of decarbonisation, one of the four overarching themes on which we base our investment approach at LGB.

 

LGB Investors were able to review the investment proposition via the LGB Deal Hub. The highlights included: 

IP/Know How: The company has a suite of patents over its technology platform as well as know-how on the formulation.

Value Proposition: The ingredient is often cheaper, offers improved performance and has better environmental credentials. As such it is expected to be disruptive as traditional markets experience significant change over the next few years under pressure to reduce their carbon footprint and improve their environmental credentials. The attractiveness of the Itaconix technology platform is that its performance ingredients can become standard inputs in many new generations of consumer product formulations, creating an attractive expanding recurring business model which is brand agnostic.

Management Team: The senior management team has a strong and relevant track record of building technology businesses.

 

Large Addressable Markets: The company has a focused approach on three large target markets in homecare, with a combined addressable market of $750m, with other consumer, commercial and industrial markets offering medium- to longer-term opportunities.

Route to Market: Accelerated market entry has been obtained through commercial partnerships.

 

Financials: The company showed a 48% compound annual growth rate over four years, with the broker forecasting this trend to continue. 

The £10.3m placing, led by finnCap, was oversubscribed with strong support from new and existing institutional investors. 

 

If you are interested in becoming a client of LGB, please get in touch for more information. Furthermore, we continue to work with companies in the digitisation, new age consumer, future of healthcare and decarbonisation sectors. We would be pleased to hear about compelling companies with validated business models in this space.